Auguron Biosciences Inc., Progenika deal

Progenika’s Proteomika S.L. subsidiary received an option to license exclusive rights to use Auguron’s Nucleic Acid Programmable Protein Array (NAPPA) technology for biomarker discovery in inflammator...